from RG's letter to Shareholders on 6/16/08:

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

d2006s

Rank: Vice President [?]

Points: 5220 [?]

Votes: 88 Score: 3.2 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

from RG's letter to Shareholders on 6/16/08:

posted on Jun 24, 2008 08:05AM

"the MMP™ portfolio licensing effort is alive and well.

We expect TPL/Alliacense will continue to pursue and close new licensees. "

remember, TPL KNOWS what is happening in the USPTO. this is an ex parte reexam and the USPTO "is" communicating directly with the Inventor Chuck Moore and therefore TPL.

either they are bluffing RG or they truly are confident that we will make it out with our Unique core technology.

PTSC owns 50% of this portfolio and TPL owns 25% of it. Let's not forget the Master agreement either...........PTSC DOES have a significant say, it's just prudent to let the experts, TPL/Alliasense deal with the Licensing and Litigation.

Still crossing my fingers that we get good news and SOON on the 148.

Calling greeneyes...............any word from you source???

TIA

5 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply